Please login to the form below
hypothyroidism
This page shows the latest hypothyroidism news and features for those working in and with pharma, biotech and healthcare.
Merck KGaA to make $3m payout to patients after drug formulation complaints
Merck KGaA removed lactose from the drug in March 2017 – a widely-used replacement treatment for hormone thyroxine in patients diagnosed with hypothyroidism – in an attempt to make it easier to
Latest news
-
Concordia accused of overcharging NHS for thyroid drug
Canadian pharma company Concordia has been accused of hiking the price of its hypothyroidism drug liothyronine by almost 6, 000% over 10 years by the UK competition authorities. ... Although liothyronine tablets are not the primary treatment for
-
FDA panel backs approval of first opioid addiction implant
The company is also testing the technology to deliver Parkinson's disease therapy ropinirole and levothyroxine for people with hypothyroidism.
-
AbbVie is not looking at another big acquisition, says CEO
Among these Synthroid (levothyroxine) for hypothyroidism grew 24% to $200m, despite its maturity and plenty of generic competition, while respiratory syncytial virus (RSV) drug Synagis (palivizumab) rose 18% to $109m.
-
AbbVie sales jump on strong Humira gains
Hypothyroidism drug Synthroid (levothyroxine) is reaching maturity - with generics well-established for many years - but managed a 24 per cent sales hike to $153m thanks to continuing brand loyalty.
-
AbbVie expects Humira to drive growth in inaugural guidance
Top of the list in the speciality division is testosterone replacement therapy AndroGel – 31 per cent to $1.15bn in 2012 – with support from Creon (pancrelipase) for pancreatic insufficiency and hypothyroidism
More from news
Approximately 2 fully matching, plus 9 partially matching documents found.
Subscribe to our email news alerts
- Roche to acquire Carmot Therapeutics in deal worth up to $3.1bn
- Eli Lilly’s Jaypirca granted FDA accelerated approval for non-Hodgkin lymphomas
- UK-India research project trialling easy-to-use UTI test to support fight against AMR
- Cancer Research UK and Guardant collaborate to advance cancer detection and treatment
- Give the gift of positive change
- Apple Vision Pro: challenges and opportunities for pharma
No results were found
PMHub
CHASE
We are a leading provider of outsourced commercial, medical and recruitment services to UK pharmaceutical, biotech and healthcare companies....
Latest intelligence
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
